Results 201 to 210 of about 623,160 (229)

Anti-nephrin antibody: a potential biomarker of minimal change disease. [PDF]

Clin Kidney J
Chen Q, Chen S, Ye Q, Lin W, Liao Y, Xiong Y, Xu J, Gao R, Li B, Liu L, Wei L.   +10 more
europepmc   +1 more source

Dengue causing relapse of minimal change disease: A double-edged sword

Asian Pacific Journal of Tropical Medicine
Sourabh Sharma, Himanshu Verma, Sanjay Kalra   +2 more
doaj   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source

How to identify IgA nephropathy presenting as nephrotic syndrome coexisting with minimal change disease? A 15-year single-center clinicopathological analysis. [PDF]

Front Immunol
Yang Y, Duan LX, Wang Y, Zhang Z, Xu QQ, Zhuo L, Li WG.   +6 more
europepmc   +1 more source

Heavy proteinuria of 25.4 g per 24 hours in a 52-year-old patient from Ethiopia with steroid-responsive minimal change disease: a case report. [PDF]

J Med Case Rep
Kassie YG, Yigzaw AA, Kedimu MW, Melaku MD, Getahun BM.   +4 more
europepmc   +1 more source

Factors associated with chronic calcineurin inhibitor nephrotoxicity in children with minimal-change disease. [PDF]

Ren Fail
Jin B, Lu Z, Cheng C, Pei Y, Chen L, Yue Z, Lin A, Yang S, Mo Y, Jiang X.   +9 more
europepmc   +1 more source

Immunoglobulin M Nephropathy: A Diagnostic Dilemma Between Minimal Change Disease and Focal Segmental Glomerulosclerosis. [PDF]

Cureus
Agrawal G, Agarwal B, Sonavane K, Shirsat P.   +3 more
europepmc   +1 more source

The role of obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease. [PDF]

Clin Kidney J
Chen Z, Xu D, Wu S, Liu W, Wu J, Yu S, Dai B, Mao Z, Gao X.   +8 more
europepmc   +1 more source

Anti-nephrin antibodies in minimal change disease: Case report series. [PDF]

Clin Nephrol
Knehtl M, Piko N, Petreski T, Zorman T, Stropnik-Galuf T, Kojc N, Wechtersbach K, Ekart R, Bevc S.   +8 more
europepmc   +1 more source

Minimal change disease following COVID-19 vaccination: A systematic review

PLoS ONE
Konstantinos S. Kechagias, Joshua D. Laleye, Jan Drmota, Georgios Geropoulos, Georgios Kyrtsonis, Marina Zafeiri, Konstantinos Katsikas Triantafyllidis, Dimitra Stathi   +7 more
doaj